Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protagonist Therapeutics (PTGX) Current Taxes (2018 - 2025)

Protagonist Therapeutics (PTGX) has disclosed Current Taxes for 3 consecutive years, with $1.9 million as the latest value for Q1 2025.

  • Quarterly Current Taxes fell 43.21% to $1.9 million in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $1.9 million through Mar 2025, down 43.21% year-over-year, with the annual reading at $2.7 million for FY2024, N/A changed from the prior year.
  • Current Taxes hit $1.9 million in Q1 2025 for Protagonist Therapeutics, down from $2.7 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $3.3 million in Q1 2024 to a low of $1.0 million in Q3 2024.